Search

Jerry B. Dennison

Examiner (ID: 40, Phone: (571)272-3910 , Office: P/2443 )

Most Active Art Unit
2443
Art Unit(s)
2443, 2409, 2143, 2419
Total Applications
1015
Issued Applications
700
Pending Applications
74
Abandoned Applications
250

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19067199 [patent_doc_number] => 20240101625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE [patent_app_type] => utility [patent_app_number] => 18/461658 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461658 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/461658
EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE Sep 5, 2023 Abandoned
Array ( [id] => 18903077 [patent_doc_number] => 20240018562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => CYCLIC LIPOPEPTIDE-PRODUCING MICROBIAL STRAIN AND METHOD FOR PRODUCING CYCLIC LIPOPEPTIDE [patent_app_type] => utility [patent_app_number] => 18/452884 [patent_app_country] => US [patent_app_date] => 2023-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18452884 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/452884
CYCLIC LIPOPEPTIDE-PRODUCING MICROBIAL STRAIN AND METHOD FOR PRODUCING CYCLIC LIPOPEPTIDE Aug 20, 2023 Pending
Array ( [id] => 19390723 [patent_doc_number] => 20240280593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS [patent_app_type] => utility [patent_app_number] => 18/231880 [patent_app_country] => US [patent_app_date] => 2023-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18231880 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/231880
METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS Aug 8, 2023 Abandoned
Array ( [id] => 18754357 [patent_doc_number] => 20230357762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE [patent_app_type] => utility [patent_app_number] => 18/351241 [patent_app_country] => US [patent_app_date] => 2023-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5131 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/351241
EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE Jul 11, 2023 Pending
Array ( [id] => 19098106 [patent_doc_number] => 20240117334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => FACTOR B PROTEASES [patent_app_type] => utility [patent_app_number] => 18/219384 [patent_app_country] => US [patent_app_date] => 2023-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32007 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219384 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/219384
FACTOR B PROTEASES Jul 6, 2023 Pending
Array ( [id] => 18972231 [patent_doc_number] => 20240052323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => MODIFIED TRANSGLUTAMINASE [patent_app_type] => utility [patent_app_number] => 18/212427 [patent_app_country] => US [patent_app_date] => 2023-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212427 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/212427
MODIFIED TRANSGLUTAMINASE Jun 20, 2023 Pending
Array ( [id] => 18939906 [patent_doc_number] => 20240035045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => ENGINEERED VIRAL CAPSIDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/315312 [patent_app_country] => US [patent_app_date] => 2023-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18315312 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/315312
ENGINEERED VIRAL CAPSIDS AND METHODS OF USE May 9, 2023 Pending
Array ( [id] => 18726234 [patent_doc_number] => 20230340501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => COORDINATED COEXPRESSION OF THROMBIN [patent_app_type] => utility [patent_app_number] => 18/310317 [patent_app_country] => US [patent_app_date] => 2023-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310317 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/310317
COORDINATED COEXPRESSION OF THROMBIN Apr 30, 2023 Abandoned
Array ( [id] => 18649763 [patent_doc_number] => 20230295584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE [patent_app_type] => utility [patent_app_number] => 18/131968 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131968 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/131968
BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE Apr 6, 2023 Pending
Array ( [id] => 18860272 [patent_doc_number] => 20230414706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES [patent_app_type] => utility [patent_app_number] => 18/296454 [patent_app_country] => US [patent_app_date] => 2023-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296454 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296454
COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES Apr 5, 2023 Pending
Array ( [id] => 18536095 [patent_doc_number] => 20230241182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => PROTEIN NANOSPHERES TO TREAT HARM FROM MULTIPLE TRAUMA [patent_app_type] => utility [patent_app_number] => 18/295829 [patent_app_country] => US [patent_app_date] => 2023-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295829 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/295829
PROTEIN NANOSPHERES TO TREAT HARM FROM MULTIPLE TRAUMA Apr 3, 2023 Pending
Array ( [id] => 18647986 [patent_doc_number] => 20230293769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING [patent_app_type] => utility [patent_app_number] => 18/123157 [patent_app_country] => US [patent_app_date] => 2023-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18123157 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/123157
ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING Mar 16, 2023 Abandoned
Array ( [id] => 18552403 [patent_doc_number] => 20230250412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => Compositions and Methods for Modulating Factor IX Function [patent_app_type] => utility [patent_app_number] => 18/176546 [patent_app_country] => US [patent_app_date] => 2023-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176546 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/176546
Compositions and Methods for Modulating Factor IX Function Feb 28, 2023 Pending
Array ( [id] => 19404045 [patent_doc_number] => 20240287556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => USING BIOSOURCED RAWS FROM WASTE STREAMS TO MAKE SOURCE MATERIALS FOR OILFIELD CHEMICAL MANUFACTURE [patent_app_type] => utility [patent_app_number] => 18/115585 [patent_app_country] => US [patent_app_date] => 2023-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115585 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/115585
USING BIOSOURCED RAWS FROM WASTE STREAMS TO MAKE SOURCE MATERIALS FOR OILFIELD CHEMICAL MANUFACTURE Feb 27, 2023 Abandoned
Array ( [id] => 18955142 [patent_doc_number] => 20240043469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => MANUFACTURE OF ENDOTOXIN-FREE HEMOGLOBIN-BASED DRUG SUBSTANCE AND METHOD FOR ENDOTOXIN-FREE PROTEIN PURIFICATION [patent_app_type] => utility [patent_app_number] => 18/115724 [patent_app_country] => US [patent_app_date] => 2023-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16008 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115724 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/115724
MANUFACTURE OF ENDOTOXIN-FREE HEMOGLOBIN-BASED DRUG SUBSTANCE AND METHOD FOR ENDOTOXIN-FREE PROTEIN PURIFICATION Feb 27, 2023 Abandoned
Array ( [id] => 18692955 [patent_doc_number] => 20230323314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES [patent_app_type] => utility [patent_app_number] => 18/161938 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18161938 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/161938
INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES Jan 30, 2023 Abandoned
Array ( [id] => 18390281 [patent_doc_number] => 20230158499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood [patent_app_type] => utility [patent_app_number] => 18/159283 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13233 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159283 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159283
Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood Jan 24, 2023 Abandoned
Array ( [id] => 18390280 [patent_doc_number] => 20230158498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood [patent_app_type] => utility [patent_app_number] => 18/159276 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159276
Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood Jan 24, 2023 Abandoned
Array ( [id] => 18404904 [patent_doc_number] => 20230166255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood [patent_app_type] => utility [patent_app_number] => 18/159281 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159281 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159281
Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood Jan 24, 2023 Pending
Array ( [id] => 18709574 [patent_doc_number] => 20230332194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO [patent_app_type] => utility [patent_app_number] => 18/158680 [patent_app_country] => US [patent_app_date] => 2023-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158680 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/158680
MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO Jan 23, 2023 Abandoned
Menu